A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography.

Abstract

To evaluate whether a low-osmolar contrast medium could decrease hyperamylasemia after endoscopic retrograde pancreatography, a prospective randomized double-blind trial of 54 consecutive patients with suspected pancreatic disease referred for endoscopic retrograde pancreatography was performed. The low-osmolar contrast medium iohexol and high-osmolar amidotrizoate were used. No statistically significant differences with regard to rise in pancreatic-type amylase, pain reaction, or diagnostic information were found. No case of acute pancreatitis was observed.

Cite this paper

@article{Jensen1985ART, title={A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography.}, author={Anni Ravnsbaek Jensen and Axel Malchow-M\oller and Peter Matzen and James E. Larsen and F B M\oller and Jesper Rye Andersen and Edward Magid}, journal={Scandinavian journal of gastroenterology}, year={1985}, volume={20 1}, pages={83-6} }